These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33541379)

  • 1. Dosimetric predictors of nephrotoxicity in patients receiving extended-field radiation therapy for gynecologic cancer.
    Kunogi H; Yamaguchi N; Terao Y; Sasai K
    Radiat Oncol; 2021 Feb; 16(1):25. PubMed ID: 33541379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney-Sparing Methods for Extended-Field Intensity-Modulated Radiotherapy (EF-IMRT) in Cervical Carcinoma Treatment.
    Kunogi H; Yamaguchi N; Terao Y; Sasai K
    PLoS One; 2016; 11(6):e0156623. PubMed ID: 27258030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer.
    Klopp AH; Moughan J; Portelance L; Miller BE; Salehpour MR; Hildebrandt E; Nuanjing J; D'Souza D; Souhami L; Small W; Gaur R; Jhingran A
    Int J Radiat Oncol Biol Phys; 2013 May; 86(1):83-90. PubMed ID: 23582248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.
    Poorvu PD; Sadow CA; Townamchai K; Damato AL; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1262-8. PubMed ID: 23182395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric predictors of duodenal toxicity after intensity modulated radiation therapy for treatment of the para-aortic nodes in gynecologic cancer.
    Verma J; Sulman EP; Jhingran A; Tucker SL; Rauch GM; Eifel PJ; Klopp AH
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):357-62. PubMed ID: 24411609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial Report of Pencil Beam Scanning Proton Therapy for Posthysterectomy Patients With Gynecologic Cancer.
    Lin LL; Kirk M; Scholey J; Taku N; Kiely JB; White B; Both S
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):181-189. PubMed ID: 26372435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
    Milby AB; Both S; Ingram M; Lin LL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison.
    Marnitz S; Wlodarczyk W; Neumann O; Koehler C; Weihrauch M; Budach V; Cozzi L
    Radiat Oncol; 2015 Apr; 10():91. PubMed ID: 25896675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin.
    Simpson DR; Song WY; Moiseenko V; Rose BS; Yashar CM; Mundt AJ; Mell LK
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e81-6. PubMed ID: 22516388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix.
    Gerszten K; Colonello K; Heron DE; Lalonde RJ; Fitian ID; Comerci JT; Selvaraj RN; Varlotto JM
    Gynecol Oncol; 2006 Aug; 102(2):182-8. PubMed ID: 16516281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended field intensity modulated radiation therapy for gynecologic cancers: Is the risk of duodenal toxicity high?
    Xu KM; Rajagopalan MS; Kim H; Beriwal S
    Pract Radiat Oncol; 2015; 5(4):e291-7. PubMed ID: 25532491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-field intensity-modulated radiotherapy and concurrent cisplatin-based chemotherapy for postoperative cervical cancer with common iliac or para-aortic lymph node metastases: a retrospective review in a single institution.
    Zhang G; Fu C; Zhang Y; Wang J; Qiao N; Yang Q; Cheng Y
    Int J Gynecol Cancer; 2012 Sep; 22(7):1220-5. PubMed ID: 22854654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
    Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small bowel toxicity in pelvic radiotherapy for postoperative gynecological cancer: comparison between conformal radiotherapy and intensity modulated radiotherapy.
    Ray A; Sarkar B
    Asia Pac J Clin Oncol; 2013 Sep; 9(3):280-4. PubMed ID: 23279854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant cisplatin and extended field radiation therapy in patients with cervical and endometrial cancer.
    Sood BM; Timmins PF; Gorla GR; Garg M; Anderson PS; Vikram B; Goldberg GL
    Int J Gynecol Cancer; 2002; 12(5):459-64. PubMed ID: 12366663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy.
    Lujan AE; Mundt AJ; Yamada SD; Rotmensch J; Roeske JC
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):516-21. PubMed ID: 12957265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies.
    Roeske JC; Lujan A; Rotmensch J; Waggoner SE; Yamada D; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1613-21. PubMed ID: 11121668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 2 contouring methods of bone marrow on CT and correlation with hematological toxicities in non-bone marrow-sparing pelvic intensity-modulated radiotherapy with concurrent cisplatin for cervical cancer.
    Mahantshetty U; Krishnatry R; Chaudhari S; Kanaujia A; Engineer R; Chopra S; Shrivastava S
    Int J Gynecol Cancer; 2012 Oct; 22(8):1427-34. PubMed ID: 22932264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
    Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
    Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dosimetric comparison between helical tomotherapy and step-and-shoot intensity modulated radiation therapy for endometrial carcinoma].
    Yang RJ; Xu SP; Jiang WJ; Wang JJ; Xie CB
    Ai Zheng; 2009 Nov; 28(11):1121-6. PubMed ID: 19895729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.